Do not stop or reduce any diabetes medicine because of this page. Losing weight and changing your diet lowers blood glucose, sometimes quickly. Insulin and sulfonylureas taken at an unchanged dose in that situation can cause dangerously low blood sugar. Take the plan to the clinician who manages your diabetes and let them adjust the medication. That is not a formality — it is the part where people get hurt.

What remission actually means

The word matters, and I want to be precise before making any claim with it.

An international consensus group defines remission as an HbA1c below 6.5% sustained for at least three months after stopping all glucose-lowering medication.1 Note what that is not. It is not a cure. The underlying susceptibility remains, the condition can return if weight is regained, and monitoring continues.

I use “remission” rather than “reversal” deliberately. Reversal implies the problem has been undone. Remission means the disease is quiet, which is honest and still remarkable.

Why this calculator refuses to give you a percentage

You will find tools online that tell you that you have a 74% chance of remission. I would rather explain why I have not built one of those.

The trials tell us a great deal about groups of people and comparatively little about any individual. DiRECT enrolled a particular population — aged 20 to 65, diabetes for under six years, BMI 27 to 45, not using insulin — and its numbers describe that population. Applying them to a 71-year-old on insulin for twelve years is not arithmetic; it is extrapolation dressed up as arithmetic.

A number invented to three significant figures is more persuasive than an honest range, and that is exactly the problem with it.

So the index above sorts you into a band and shows you the weight-loss targets. That is what the evidence supports.

What the trials found

DiRECT: remission by weight lost, at 12 months

  • 0% among those who gained weight
  • 7% for 0–5 kg lost
  • 34% for 5–10 kg
  • 57% for 10–15 kg
  • 86% for 15 kg or more2

Overall, 46% of the intervention group were in remission at one year against 4% of controls, and 36% remained in remission at two years.2,3 This was done in ordinary general practices, not a research hospital.

That gradient is the single most useful thing in this field. Remission is not a lottery. It tracks how much weight comes off and stays off, and it does so steeply.

A 2025 systematic review and meta-regression of 22 randomised trials and more than 12,000 people confirmed the dose-response relationship holds irrespective of age, BMI, diabetes duration, HbA1c or the type of intervention used. Complete remission occurred in 0.7% of those losing under 10% of body weight, rising to 49.6% at 20–29% and 79.1% at 30% or more.4

Read that first figure again. Under 10% weight loss, remission was close to non-existent. This is why the calculator weights your realistic weight-loss goal far more heavily than anything else you enter.

What about duration, HbA1c and insulin?

They matter, but less than people assume, and they are contextual rather than decisive.

Shorter duration means more recoverable beta-cell function. A 2026 randomised trial put numbers on it: after a three-month very-low-calorie diet, remission reached 82% in those diagnosed within four years against 50% in those with eight years or more — despite similar weight loss in both groups.5

Fifty percent. In people who had been diabetic for the better part of a decade. That is the number I would put in front of anyone who has been told it is too late.

On insulin, and being told you are not a candidate

Most lifestyle-remission trials excluded people using insulin. That makes the evidence thin for that group, not negative — an important distinction that gets lost.

A 2025 analysis of Look AHEAD tested exactly this. It compared people who met the usual remission-eligibility criteria (under six years, no insulin) against those who did not, and found eligibility did not modify the effect of intensive lifestyle intervention on cardiovascular disease, kidney disease or mortality. The authors concluded the extra benefit in “eligible” people was too small to justify restricting the programme to them.6

In plain terms: even if remission is unlikely for you, the intervention is still worth doing, because the outcomes that matter most are not conditional on remission.

Work out your actual energy needs first Weight loss is the engine here, and almost everyone estimates their requirement too high. Five minutes, free.
Calculate my needs →

What a remission plan actually looks like

There is no magical diabetes diet. The goal is a pattern that improves insulin sensitivity, removes excess fat from the liver and pancreas, improves fitness, and — the part everyone underestimates — can be sustained long enough to matter.

1 · Create a real, sustained energy deficit

Pick an eating pattern you can actually follow. Structured programmes typically aim for a deficit of roughly 500–750 kcal a day, with nutrition, activity and behavioural support together rather than a leaflet.7

2 · Minimally processed, high-fibre food

Vegetables, whole fruit, legumes, whole grains, nuts and seeds, with adequate protein. Mediterranean, plant-predominant and lower-carbohydrate patterns can all work. The Adventist Health Study-2 data is where I would start.

3 · Move most weeks

At least 150 minutes a week of moderate activity across three or more days, plus resistance work twice weekly where appropriate. Break up long periods of sitting.8

4 · Treat sleep as part of the treatment

Regular sleep and wake times, a consistent wind-down, a dark quiet room. Ask about obstructive sleep apnoea — it is common in this group and frequently missed.

5 · Measure the things that move

Weight, waist, glucose and HbA1c, what you actually eat, what you actually do. The purpose is feedback, not a report card.

6 · Keep your clinician in the loop

As glucose falls, medication needs change — and so, often, do blood pressure tablets. Reducing them safely is part of the treatment, not an afterthought.

The honest summary: a plan that works is structured, intensive enough to produce meaningful weight loss, supervised where medication is involved, and built for maintenance rather than for a heroic twelve weeks.

If your profile came out less favourable

I want to say something directly to you, because a page like this can land badly.

A less favourable profile means drug-free remission is a harder target. It does not mean the effort is wasted, and I have watched too many people conclude otherwise. Lowering your HbA1c, losing weight, improving fitness and reducing your medication burden are all real clinical wins that lower your risk of the things you are actually afraid of — the heart attack, the kidney failure, the amputation, the stroke. The Look AHEAD analysis above found those benefits were not restricted to the people eligible for remission.6

Remission is a good goal. It is not the only one worth having.

The full programme, in one place

$39 pre-launch $59 after

Launching October 2026. Buy now at the pre-launch price and receive it the day it is released.

Dr. Gily Ionescu, MS MD

References

Every figure in the calculator and the text above comes from one of these.

  1. Riddle MC, Cefalu WT, Evans PH, et al. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetes Care. 2021;44(10):2438–2444. https://doi.org/10.2337/dci21-0034 The definition of remission used throughout this page.
  2. Lean MEJ, Leslie WS, Barnes AC, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet. 2018;391(10120):541–551. https://doi.org/10.1016/S0140-6736(17)33102-1 Used for 46% remission at 12 months and the full weight-loss gradient: 0%, 7%, 34%, 57%, 86%.
  3. Lean MEJ, Leslie WS, Barnes AC, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. The Lancet Diabetes & Endocrinology. 2019;7(5):344–355. https://doi.org/10.1016/S2213-8587(19)30068-3 Used for 36% still in remission at two years.
  4. Kanbour S, Ageeb RA, Malik RA, Abu-Raddad LJ. Impact of bodyweight loss on type 2 diabetes remission: a systematic review and meta-regression analysis of randomised controlled trials. The Lancet Diabetes & Endocrinology. 2025;13(4):294–306. https://doi.org/10.1016/S2213-8587(24)00346-2 22 trials, 12,000+ participants. Used for the 0.7% / 49.6% / 79.1% figures and for the finding that the dose-response holds regardless of age, BMI, duration or HbA1c.
  5. Schuppelius B, Lalama E, Zhang J, et al. Remission of type 2 diabetes depends on time since diagnosis and low-calorie diet composition: results of a randomized controlled trial in individuals with overweight and obesity. Diabetes Research and Clinical Practice. 2026. https://doi.org/10.1016/j.diabres.2026.113159 Used for 82% remission at under four years' duration against 50% at eight years or more.
  6. Gong YJ, Salim A, Magliano DJ, Shaw JE. Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: the Look AHEAD trial. Diabetes, Obesity and Metabolism. 2025;27(10):5930–5937. https://doi.org/10.1111/dom.16650 Used for the finding that remission eligibility did not modify the effect of lifestyle intervention on cardiovascular disease, kidney disease or mortality.
  7. American Diabetes Association Professional Practice Committee. 8. Obesity and weight management for the prevention and treatment of diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S166–S182. diabetesjournals.org Used for the structured-programme and energy-deficit guidance.
  8. American Diabetes Association Professional Practice Committee. 5. Facilitating positive health behaviors and well-being to improve health outcomes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S89–S131. diabetesjournals.org Used for the physical activity and sleep recommendations.